Land: Malta
Tungumál: enska
Heimild: Medicines Authority
ESCITALOPRAM
H. Lundbeck A.S. 9 Ottiliavej, 2500 Valby, Copenhagen, Denmark
N06AB10
ESCITALOPRAM 10 mg
FILM-COATED TABLET
ESCITALOPRAM 10 mg
POM
PSYCHOANALEPTICS
Authorised
2006-11-21
1 PACKAGE LEAFLET: INFORMATION FOR THE USER CIPRALEX 5 MG FILM-COATED TABLETS CIPRALEX 10 MG FILM-COATED TABLETS CIPRALEX 20 MG FILM-COATED TABLETS escitalopram READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Cipralex is and what it is used for 2. What you need to know before you take Cipralex 3. How to take Cipralex 4. Possible side effects 5. How to store Cipralex 6. Contents of the pack and other information 1. WHAT CIPRALEX IS AND WHAT IT IS USED FOR _ _ Cipralex contains the active substance escitalopram. Cipralex belongs to a group of antidepressants called selective serotonin reuptake inhibitors (SSRIs). These medicines act on the serotonin-system in the brain by increasing the serotonin level. Cipralex is used to treat depression (major depressive episodes) and anxiety disorders (such as panic disorder with or without agoraphobia, social anxiety disorder, generalised anxiety disorder and obsessive- compulsive disorder). It may take a couple of weeks before you start to feel better. Continue to take Cipralex, even if it takes some time before you feel any improvement in your condition. You must talk to a doctor if you do not feel better or if you feel worse. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE CIPRALEX DO NOT TAKE CIPRALEX • if you are allergic to escitalopram or any of the other ingredients of this medicine (listed in section 6). • if you take other medicines which belong to a group called MAO inhibitors, including selegiline (used in the treatment of Parkinson´s diseas Lestu allt skjalið
Page 1 of 17 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF MEDICINAL PRODUCT CIPRALEX 5 mg film-coated tablets CIPRALEX 10 mg film-coated tablets CIPRALEX 20 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Cipralex 5 mg: Each tablet contains 5 mg escitalopram (as oxalate) Cipralex 10 mg: Each tablet contains 10 mg escitalopram (as oxalate) Cipralex 20 mg: Each tablet contains 20 mg escitalopram (as oxalate) For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Film-coated tablet Cipralex 5 mg: Round, white, film-coated tablet of 6 mm marked with "EK" on one side. Cipralex 10 mg: Oval, white, scored, film-coated tablet of 8x5.5 mm marked with "E” and “L" on each side of the score on one side of the tablet. Cipralex 20 mg: Oval, white, scored, film-coated tablet of 11.5x7 mm marked with "E” and “N" on each side of the score on one side of the tablet. The 10, 15 and 20 mg tablets can be divided into equal doses. _ _ _ _ 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of major depressive episodes. Treatment of panic disorder with or without agoraphobia. Treatment of social anxiety disorder (social phobia). Treatment of generalised anxiety disorder. Treatment of obsessive-compulsive disorder. Page 2 of 17 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Safety of daily doses above 20 mg has not been demonstrated. _Major depressive episodes _ Usual dosage is 10 mg once daily. Depending on individual patient response, the dose may be increased to a maximum of 20 mg daily. Usually 2-4 weeks are necessary to obtain antidepressant response. After the symptoms resolve, treatment for at least 6 months is required for consolidation of the response. _Panic disorder with or without agoraphobia _ An initial dose of 5 mg is recommended for the first week before increasing the dose to 10 mg daily. The dose may be further increased, up to a maximum of 20 mg daily, dependent on individual patient response. Maximum effectiveness is reached after about 3 months. The treatme Lestu allt skjalið